Werewolf Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -400 | -406 | |
EBITDA | -6,612 | -15,324 | -16,275 |
EBIT | -7,012 | -15,726 | -16,681 |
Net Income | -8,381 | -16,370 | -17,982 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -11,024 | -15,156 | -15,164 |
Cash | 57,050 | 65,711 | 77,596 |
Basic Shares | 46,810 | 45,804 | 44,981 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $1,885 | $19,943 | $16,401 |
Gross Profit | -1,634 | 71 | 18,179 | 16,401 |
EBITDA | -59,043 | -64,045 | -32,465 | -54,952 |
EBIT | -60,677 | -65,859 | -34,229 | -56,056 |
Net Income | -60,822 | -70,515 | -37,368 | -51,564 |
Net Change In Cash | 0 | 1,885 | 19,943 | 16,401 |
Cost of Revenue | -28,301 | |||
Free Cash Flow | -60,292 | -56,442 | -33,381 | -44,207 |
Cash | 57,951 | 110,995 | 134,343 | 129,315 |
Basic Shares | 46,810 | 43,859 | 35,646 | 28,864 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.28 |
2025-12-31 | -$0.17 |
2025-09-30 | -$0.36 |
2025-06-30 | -$0.40 |